Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan

Shunji Mugikura; Miki Fujimura; Shoki Takahashi; Kei Takase

doi:10.1148/radiol.2017170252

Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan

Shunji Mugikura, Miki Fujimura, Shoki Takahashi, Kei Takase

Tohoku University

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	301-302
Number of pages	2
Journal	Radiology
Volume	284
Issue number	1
DOIs	https://doi.org/10.1148/radiol.2017170252
Publication status	Published - 2017 Jul

Access to Document

10.1148/radiol.2017170252

Cite this

@article{cddb0922e58945269c7b4905a74f4fef,

title = "Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan",

author = "Shunji Mugikura and Miki Fujimura and Shoki Takahashi and Kei Takase",

year = "2017",

month = jul,

doi = "10.1148/radiol.2017170252",

language = "English",

volume = "284",

pages = "301--302",

journal = "Radiology",

issn = "0033-8419",

publisher = "Radiological Society of North America Inc.",

number = "1",

}

TY - JOUR

T1 - Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan

AU - Mugikura, Shunji

AU - Fujimura, Miki

AU - Takahashi, Shoki

AU - Takase, Kei

PY - 2017/7

Y1 - 2017/7

UR - http://www.scopus.com/inward/record.url?scp=85021052764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021052764&partnerID=8YFLogxK

U2 - 10.1148/radiol.2017170252

DO - 10.1148/radiol.2017170252

M3 - Letter

C2 - 28628405

AN - SCOPUS:85021052764

SN - 0033-8419

VL - 284

SP - 301

EP - 302

JO - Radiology

JF - Radiology

IS - 1

ER -

Further implications of off-label use of acetazolamide in the management of moyamoya disease in Japan

Access to Document

Other files and links

Cite this